Navigating the FDA's New Ruling on Semaglutide and Tirzepatide - April 2025
Update: 2025-04-18
Description
In this episode of "What's Up, Doc?", Dr. John Bender and his trusted colleague, Janessa Hanna, discuss the latest FDA ruling that impacts semaglutide and tirzepatide GLP-1 medications. They dive into what this means for patients nationwide, especially in light of the discontinued production of compounded medications during the national shortage. The team also explores emerging options for personalized, compounded preparations to address side effects and shares insights into the evolving pharmaceutical landscape. Stay informed with this crucial update from Miramont Wellness Centers.
đ§Listen to our Podcast đ§
Spotify:Â â https://open.spotify.com/show/3yDSFFDkuYhY4mYocsTPjO?si=7721b690782a4a0bâ Â
ApplePodcasts:Â â https://podcasts.apple.com/us/podcast/whats-up-doc/id1746818880â Â
Learn more about Miramont Wellness Centers.
https://miramont.usâ Â
Call Us: (970) 225-5000
#SemaglutideUpdates #WeightLossJourney #MiramontWellnessCenters #GLP1 #Ozempic #WeightLossPlateau #Ketosis #SemaglutideAlternative #WellnessPodcast #WhatsUpDoc #FDA #Nationaldrugshortage
đ§Listen to our Podcast đ§
Spotify:Â â https://open.spotify.com/show/3yDSFFDkuYhY4mYocsTPjO?si=7721b690782a4a0bâ Â
ApplePodcasts:Â â https://podcasts.apple.com/us/podcast/whats-up-doc/id1746818880â Â
Learn more about Miramont Wellness Centers.
https://miramont.usâ Â
Call Us: (970) 225-5000
#SemaglutideUpdates #WeightLossJourney #MiramontWellnessCenters #GLP1 #Ozempic #WeightLossPlateau #Ketosis #SemaglutideAlternative #WellnessPodcast #WhatsUpDoc #FDA #Nationaldrugshortage
CommentsÂ
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
